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Persistent infection (PI) with Bovine Viral Diarrhea Virus (BVDV) is a major
source of economic loss for the livestock industry. Persistent infection occurs when a
dam is exposed to the virus during 42 to 125 days of gestation and the virus is passed to
the fetus without an adaptive immune response. These PI calves serve as continuous
sources of infection to others. The identification of differences in expression of gene
networks and/or genetic markers associated with infection could assist in the
development of novel strategies to prevent, control, or treat BVDV. To examine the host
response to PI, RNA-Seq data were obtained from blood of cattle naturally infected and
PI with BVDV strains 1a (n=10), 1b (n=8), and 2 (n=8). Additional data were collected
from two comparison groups, a high exposure group with one positive test for the virus
that were later confirmed negative for PI (n=9), and an unexposed group from a closed
herd (n=10). Sequencing on an Illumina NextSeq resulted in 58 million stranded pairedend reads per animal which were aligned to the UMD3.1 bovine genome. With 86% of
the reads aligning and the quantification of 22,915 transcripts, differential expression
analyses revealed there were no significant differentially expressed transcripts between
the strain subtypes and among the strains of PI cattle. There were 1,032 differentially
expressed transcripts between the PIs and the high exposure group; this is the comparison
that was focused on in further analyses. The differential expression data were examined

for gene network relationships. The top significant canonical pathways represented by the
expression data were interferon signaling and activation of interferon response factors by
cytosolic pattern recognition receptors. There were significant predictions of decreased
replication of viruses and decreased risk of viral infection for the BVDV-PIs. These
results suggest that the BVDV-PIs may have an innate immune response to BVDV since
the directionality of their gene expression supports the presence of a viral infection when
compared to high exposure animals.
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CHAPTER I: A LITERATURE REVIEW
History of Bovine Viral Diarrhea Virus
In 1946, Bovine Viral Diarrhea Virus was first described as an acute, contagious,
and transmissible disease in cattle after an outbreak in a large dairy herd in New York. It
was characterized by many clinical symptoms including severe diarrhea, weight loss,
abortions, and a 4-8% mortality rate (Olafson et al., 1946). In the same year in
Saskatchewan, Canada, “X disease” was described as having similar symptoms as the
severely infected cattle in New York. Collectively these diseases from New York and
Canada became known as virus diarrhea of cattle (Goens, 2002). In the 1950s Iowa State
University started to observe cases of illness similar to virus diarrhea, yet they believed
they were observing a new disease due to differences in nasal discharge, reoccurrence,
and gross lesions (Underdahl et al., 1957). This differentiated disease was termed
mucosal disease. It wasn’t until the 1960s that enough similarities between virus diarrhea
and mucosal disease were observed that a consensus was formed that they were in fact
the same disease with minor variations. It became known as bovine viral diarrheamucosal disease complex (Jubb, 1985).
In the early 1990s, mucosal disease and BVDV were studied in depth to
specifically classify each disease. Mucosal disease was discovered to occur only in PI
cattle after a second infection of a cytopathic strain, genetically similar to the initial noncytopathic, appeared; the combination of the two viruses is observed to cause more
severe disease than either one alone (Sopp et al., 1994; Bolin, 1995). After several major
hemorrhagic outbreaks in the 1980s and 1990s across the world, it appeared that there
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was more variation in virulence of the non-cytopathic biotype resulting in the need of
advanced techniques to classify the various BVDV strains.
Studies of experimental infections in pregnant cattle and neonatal calves
discovered that congenitally infected calves would be persistently infected (PI) and
would not produce antibodies against the virus, but it wasn’t until the discovery of a two
year old PI bull that the idea of PI while still being immunocompetent was widely
accepted (Johnson and Muscoplat, 1973; Coria and McClurkin, 1978). Only noncytopathic strains of the virus possess the ability to cause PI, and window for infection is
limited to 42-125 days of gestation (McClurkin et al., 1984; Brownlie et al., 1989).
These PI animal serve as a constant source for infection for any cattle that they may come
into contact with directly or indirectly since they constantly shed the virus for their entire
life (McClurkin et al., 1984).

Detection of Persistent Infection
Calves can have a transient, acute infection or PI of BVDV. In order to determine
the difference, multiple tests must be completed. The initial test for infection utilizes an
antigen capture Enzyme-Linked Immunosorbent Assay (ELISA). An ELISA contains
antibodies specific to a pathogen attached to a plastic surface. An antigen sample is added
and if the correct antigen is present they will bind to the antibodies. Next a second
antibody with a marker is added and if there is a positive reaction the marker will have a
visible color change. This test can also be utilized for testing for the presence of
antibodies, but since persistent infection results in the absence of antibodies the version
testing for the presence of the virus is used. An acute infection clears the system
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approximately in two weeks so suspected persistent infection requires retesting after a
minimum of three weeks. In order to avoid possible bias from utilizing the same test,
persistent infection can be confirmed with immunohistochemistry or PCR.
Immunohistochemistry is a process of detecting antigens in cells of a tissue
section through a color change. With a similar process to an ELISA, the color change is
achieved through an antibody conjugated to an enzyme that catalyzes a color reaction
through staining or by a fluorescent tag on the antibody. With PI, the antigen is
embedded deeper within the tissues while in an acute infection the antigen is localized to
specific areas. PCR will amplify highly conserved sequences of the antigens genome to
high levels for detection of the virus, if there is no amplification, the virus is not present.
Initial detection followed by a positive second detection after a minimum of three weeks
identifies persistent infection rather than an acute infection.

Virus Taxonomy
BVDV strains are divided between two biotypes, cytopathic and non-cytopathic,
based on their behavior in cell culture and arrangement differences of the non-structural
NS3/p80 gene (Baker, 1987; Meyers and Thiel, 1996). Expression of the NS3 protein
either by introduction of a cleavage site into the NS2/3 gene or by duplication of the NS3
protein coding sequence of a non-cytopathic biotype can induce a biotype switch to
cytopathic (Donis and Dubovi, 1987). When by recombination or rearrangement a
cleavage site is introduced into the NS3/p80 protein gene, a non-cytopathic strain mutates
into a cytopathic strain which results in mucosal disease due to co-infection of the two
biotypes (Donis, 1995; Fritzemeier et al., 1997). The cytopathic biotype induces
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cytoplasmic vacuolation and results in cell death two to three days after inoculation of
cell cultures (Lee and Gillespie, 1957; Gillespie et al., 1960). The non-cytopathic biotype
can be isolated from acute infections and is the only biotype that can establish PI (Liess et
al., 1974; McClurkin et al., 1984). When bovine fetuses were challenged with a
cytopathic strain during 63 and 107 days of gestation no PIs were established supporting
only non-cytopathic strains can establish PI (Brownlie et al., 1989). Greater than 90% of
infections, persistent or acute, are identified to be originating from the non-cytopathic
biotype (Dubovi, 1992). The high infectious rate is due to the greater volume of nasal
shedding of non-cytopathic strains as compared to cytopathic strains, and because the
main vector of infection is through the respiratory tract (Ohmann, 1983; Wentink et al.,
1991; Lambot et al., 1998). On the other hand, the cytopathic biotype is uncommon and
is most commonly isolated from fatal cases of mucosal disease when a persistent noncytopathic strain mutates and gives rise to a homologous cytopathic strain (Brownlie et
al., 1987; Howard et al., 1987; Moennig et al., 1990).
BVDV originally was placed within the Togaviridae family, but due to the
similarities in genome organization and methods of replication the virus was reclassified
as a Flaviviridae pestivirus (Westaway et al., 1985; Collett et al., 1988; Collett et al.,
1991; Horzinek et al., 1991). Pestiviruses are nonsegmented, single-stranded, sense RNA
viruses. The genome of BVDV consists of 1 open reading frame flanked by 2
untranslated regions and is approximately 12.3 kilobases (Kuta et al., 2015). The first
protein, Npro, is a viral protease followed by the structural protein genes, capsid, and
three envelope glycoproteins at the 5’ end of the open read frame. These are then
followed by six nonstructural protein genes on the non-cytopathic genome: NS2/3, 4A,
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4B, 5A, and 5B (Donis, 1995). Viral gene expression occurs via synthesis of a
polyprotein with subsequent proteolytic processing mediated by cellular and viral
proteases (Collett et al., 1988; Wiskerchen et al., 1991; Wiskerchen and Collett, 1991;
Rümenapf et al., 1993; Thiel et al., 1993). One of the highly variable regions in the
BVDV genome is the E2 region which produces a protein that elicits an antibody
response (Donis, 1995). On the other hand, the 5’ untranslated region (UTR) is highly
conserved since it serves the purpose of starting translation for the open reading frame
(ORF); it is also based on this region that two major subtypes of BVDV, BVDV1 and
BVDV2, are distinguished (Ridpath et al., 1994).
BVDV2 was first classified in 1994 after the death of 25% of all of the veal calves
in Quebec in 1993. With a 30% difference in the 5’ UTR sequence compared to the
BVDV1 strains but maintaining the same secondary structure with serological
crossreactivity, BVDV was split into two groups: BVDV1 and the new strain BVDV2
(Pellerin et al., 1994). Comparisons of BVDV genomes results in 70% or less sequence
similarities between BVDV1 and BVDV2 when comparing the 5’ UTR while the
subtypes of each strain share at least 88% sequence (Ridpath et al., 1994; Ridpath and
Bolin, 1995). The general rate of divergence for RNA viruses is estimated to be 0.032.0% per nucleotide per year, this rate along with the replication rate can give rise to a
plethora of genetically variable virus within a single host (Strauss et al., 1996). The
subtypes of each strain are named sequentially with letters. For instance, seventeen
BVDV1 subtypes have been identified and are recognized as BVDV1a to BVDV1q.
Only three BVDV2 subtypes have been recognized, and recently, a third strain, BVDV3,
has been identified and termed HoBi-like virus (Luzzago et al., 2014).
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Point mutations and deletions are extremely common in BVDV due to viral
polymerases which lack the ability to proofread and correct errors during replication.
Additionally, recombination can occur between the host and the virus when host RNA
sequences are inserted into viral genome. Without the p80 gene, which controls the
cytopathicity of the virus, BVDV2 can cause severe hemorrhagic syndrome (Bolin and
Ridpath, 1992; Ridpath and Bolin, 1995).
While the two main genotypes have been identified worldwide the subtypes are
geographically segregated. The three major subtypes circulating within the United States
are BVDV1a, 1b, and 2a. A complete genome sequencing study was conducted by
Workman et al. (2016) in order to identify the prevalence of current subtypes within the
central United States and investigate genetic variation among the viruses. Nineteen de
novo BVDV genomes were assembled by RNA sequencing from plasma collected from
confirmed PI calves. The complete coding sequences along with the 5’ UTR sequences
were compared to 75 full length BVDV genomes available in GenBank. For the BVDV1
subtypes there were no phylogenetic differences between the 5’ UTR and complete
coding sequence classifications. Meanwhile, phylogenetic analysis of the complete
coding sequences resulted in more distinct genetic classification of the BVDV2 subtypes.
From the Workman et al. (2016) study classification based on 5’ UTR analyses alone
may not be enough to provide correct identification of virus subtypes crucial for
vaccination protocols and eradication efforts.
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Economical Impact
Bovine Viral Diarrhea Virus has widespread economic impacts on the cattle
industry across the world. In dairy and beef production, 2.7% of randomly selected herds
in the United States have confirmed PI calves, and 7% of the dams of PI calves were
confirmed to be PI themselves (Wittum et al., 2001). Feedlot prevalence of BVDV PI has
been identified to range from 0.3% to 2.6% (Loneragan et al., 2005; Hessman et al.,
2009). Economically, $93.52/animal is lost for exposure to PI cattle of which
$88.26/animal is attributed to performance losses and the remaining $5.26/animal results
from an increase in fatality percentage. Outbreaks in the dairy industry alone can cause
losses of $40,000 to $100,000 per herd due to mortality, decreased milk production, and
abortions (Carman et al., 1998). At the population level, losses are estimated at $10-57
million per 1 million calvings in the US alone (Houe, 1999).
Performance loss is a major factor in profitability of the cattle industry. The goal
of the beef industry is to produce calves that have reached a certain weight for slaughter,
but when an animal is placed under stress by an acute or PI their performance suffers as
the process of energy storage shifts to energy metabolism. PI calves weigh around 73.5
kg less than non-PI calves at weaning due to secondary infections (Waldner and
Kennedy, 2008). Unexposed cattle convert feed into body weight 55% more efficiently
than cattle who have direct exposure to PI calves (Hessman et al., 2009). Non-PI cattle
exposed to PI cattle have significantly lower weight gain and average daily gain, and
have significantly higher F:G ratios than unexposed non-PI cattle (Hessman et al., 2009;
Grooms et al., 2014). Calves with antibody titers above 1,000 against BVDV1 and
BVDV2 weigh 13-15 kg less than calves with lower titers (O'Connor et al., 2001;
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Waldner and Kennedy, 2008). The mean cost of gain for direct exposure to PI cattle is
two times higher than cost of gain for unexposed cattle (Hessman et al., 2009). Out of all
of the PI cattle in feedlots 10.8% are determined to be chronically ill and sold for salvage
slaughter as compared with 3.6% of the non-PI cattle. With the decrease in performance
to the point of the animals considered for salvage, the effects of BVDV-PI animals spread
beyond themselves and to the entire feedlot.
PI cattle are at a greater risk of chronic illness due to the synergetic effects of PI
and they will need to be repeatedly treated for health concerns as compared to non-PI
cattle (Hessman et al., 2009). The odds of treatment of a PI calf is approximately 6.3
times that of a non-PI calf, and the number of total treatments is about 3.1 times higher
for PI calves (Waldner and Kennedy, 2008). Non-PI cattle, vaccinated and unvaccinated,
exposed to PI cattle have almost 6 times higher the incidence rate of an additional
treatment when compared to non-exposed cattle (Grooms et al., 2014). Treatments for
respiratory tract diseases were 43% greater in feedlot cattle who had opportunity for
direct contact with a PI animal, and 15.9% of initial treatments for respiratory tract
diseases were attributed to exposure to a PI animal (Loneragan et al., 2005). The need to
treat an animal multiple times with antibiotics increases costs, stress on the animal, and
has the potential to contribute to increasing antibiotic resistant pathogens.
Due to the immunosuppressant effects of BVDV, PI cattle have higher mortality
rates than non-PI cattle, however even exposure to PI cattle can increase the mortality
rate of non-PI herd mates. The risk of calf death is higher in herds in which at least one PI
calf is identified as compared to herds with no PI calves, and this risk increases with the
continual presence of a PI calf (Waldner and Kennedy, 2008). This effect is compounded
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in a feedlot environment where cattle from multiple sources are gathered at a single
location in close proximity. In feedlots, PI cattle have a fatality chance 23.2% higher than
non-PI cattle, but even exposure, direct or indirect, to a PI animal increases the chances
of having at least 1 fatality in a feedlot by a factor of 4 (Hessman et al., 2009). Non-PI
cattle, vaccinated and unvaccinated, exposed to PI cattle have double the incidence rate
of morbidity as compared to non-exposed cattle (Grooms et al., 2014). Overall, feedlot
postmortem examinations have identified that 2.5% of all deaths were attributed to the
presence of a BVDV PI individual (Loneragan et al., 2005).

Genetic Understandings
Gaining an understanding of the genetic interactions between infected cattle and
BVDV will allow for further development of eradication efforts through genetic testing
and selective breeding, and potentially lead to new therapeutic targets. The difference in
establishing PI between cytopathic and non-cytopathic biotypes has been identified as an
area which needs further exploration. Unlike cytopathic strains, non-cytopathic strains do
not induce type one interferons in vitro. It has been proposed that the absence of an
interferon response of the host is what allows non-cytopathic strains to develop into PIs
(Diderholm and Dinter, 1966; Nakamura et al., 1995; Adler et al., 1997). Charleston et al.
(2001) detected non-cytopathic BVDV in both the amniotic fluid and fetal spleen while
cytopathic BVDV was only detectable in the fetal spleen. These results suggest that the
fetus has a mechanism in place to limit viral replication of cytopathic strains but has no
control against non-cytopathic strains. Investigating further, Charleston et al. (2001)
confirmed that fetuses had minimal to no production of type one interferons in response
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to non-cytopathic strains but postnatal did produce a response, and cytopathic strains
produced a response at all time points. Based on these findings there is an interaction
between the virus and the host which allows for the establishment of PI by noncytopathic strains that needs to be further researched.
Estimates for heritability for bovine respiratory disease (BRD) resistance range
from 0.10 to 0.48 depending on the breed composition and age of the cattle (MuggliCockett et al., 1992; Snowder et al., 2005, 2006; Heringstad et al., 2008). Heritability
estimates for BVDV-PI have not been reported; however BVDV is included in the
complex of viruses that make up BRD and therefore the estimates for BRD resistance
account for a portion of BVDV-PI (Neibergs et al., 2011). A study conducted by
Neibergs et al. (2011) examined loci linked with BRD complex through a genome wide
linkage study of microsatellites. The authors then determined if these same loci were
associated with PI of BVDV. This approach was taken due to identification of over 65%
of BRD complex infections being co-infected with BVDV (Fulton et al., 2000). The two
pathogens are often identified together due to the immunosupression created by BVDV
which allows for a synergistic relationship with BRD pathogens (Campbell, 2004).
Utilizing a Brahman x Hereford sire half-sib family to capture Bos indicus and Bos taurus
influence respectively, linkage analyses suggested two quantitative trait loci (QTL) on
chromosome 2 and 26. With additional microsatellite markers evenly spaced within each
QTL to narrow the regions, and with additional data from 3 crossbred half-sib families,
linkage to BRD was narrowed to one peak on chromosome 2 and two peaks on
chromosome 26. These same 13 markers were then tested for association with BVDV-PI
in PI calves and their dams. On chromosome 26, four loci were associated with the PI
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calves while three different loci were associated with PI in the dams. If these data are
supported in future studies, they suggest that selection protocols for the calves or the
dams may need to be considered independently. In contrast, on chromosome 2, four loci
were associated with PI of both the calves and their dams. Selection for these regions
could prove to be beneficial to improve resistance to BVDV, or could contain
information on the mechanisms through which the virus and host interact. Additionally,
two loci on chromosome 2 were associated only with the dams of PI calves. Overall,
three loci were identified to be linked to BRD and were also associated with BVDV-PI in
claves and their dams. With continued focused research into genetic susceptibility or
resistance to BVDV, loci can be selected for to improve the welfare of cattle.
In a follow up study to Neibergs et al. (2011), Zanella et al. (2011) refined the
identified loci associated with PI of BVDV and BRD by analyzing 142 SNPs on
chromosome 2 and 173 SNPS on chromosome 26. Multiple model types were run over
all SNPs on a chromosome to identify genetic associations and then haplotype analyses
were performed to identify if a haplotype would provide greater information for an
association than a single SNP (Butler et al., 2005; Barrett, 2009). A locus was defined by
SNPs that were individually associated with BVDV-PI, and haplotypes were constructed
of SNPs that were individually associated but had a stronger association when grouped
together. On chromosome 2, 33 SNPs and 11 haplotypes were associated with the dams
of PI calves, while 9 SNPs and 4 haplotypes were associated with the PI calves. All four
of the PI calves haplotypes overlapped with those associated with the dams suggesting
these regions are associated with BVDV-PI in both the dams and the calves. For
chromosome 26, there were 18 SNPs and 8 haplotype loci to be associated with the dams
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of PI calves. The dominant model shared 17 of these SNPs, the most out of any of the
models, suggesting a dominant mechanism of gene action. BVDV-PI was associated with
29 SNPs on chromosome 26, and 11 haplotypes were identified. Six of these haplotype
loci overlapped with loci identified to be associated with the dams of PI calves while the
other five loci were unique to the PI calves. Overall the loci identified in the previous
study were refined from approximately 7.4Mb down to 93kb-2Mb in size. On
chromosome 2 all of the haplotypes associated with the PI calves were also associated
with the dams, but there were seven additional haplotypes associated with only the dams.
On chromosome 26, six of the eight loci associated with dams were shared with the PI
calves while only six of the eleven loci associated with the calves were shared with the
dams. From these analyses there is evidence to hypothesize that there are common and
unique methods involved in the fight against persistent infection between the dam and the
calves. Perhaps with further investigation into these shared loci an opportunity for
selection will assist in limiting the effects of BVDV-PI and additionally BRD.
A genome wide association study to determine if regions containing SNPs could
be associated with PI of BVDV was conducted based on 777,000 SNP markers by Casas
et al. (2015). Persistently infected calves were identified by an antigen capture ELISA
test and within 48 hours a second sample was taken for retest to confirm the PI status;
this time frame does draw into question the validity of the diagnosis of PI. DNA was
pooled from 1,200 affected and 1,200 unaffected calves in order to capture the allele
frequencies of the population; from the affected and unaffected groups a subset of 192
from each, were genotyped for associated SNPs. One SNP on chromosome 14 had a
strong association while fifteen other SNPs on chromosomes 1, 2, 6, 8, 10, 15, and 18
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were identified to have moderate association with BVDV-PI. The SNP on chromosome
14 resides within the Raly RNA binding protein-like gene which has been proposed to
have a function in mRNA splicing and 3’ formation of pre-mRNA (Jiang et al., 1998).
This gene is down regulated in human cells infected with the swine influenza virus and it
is possible that BVDV may have a similar function but gene expression analyses will
need to be conducted for further understanding of this SNP effect in cattle (Wu et al.,
2013). With three moderately associated SNPs located on chromosome 2, these may
suggest support for the findings of Neibergs et al. (2011) and Zanella et al. (2011) but are
not conclusive due to the difference in location of 20Mb between markers. One
moderately associated SNP on chromosome 10 is in high linkage disequilibrium with a
gene that was found to have an association with chronic kidney disease in humans. In
chronic kidney disease, RNA viruses from the Flaviviridae family trigger the release of
interferons in cells but once the virus enters the cytoplasm of the cell it stops the
interferon antiviral mechanism. This association could be possibly provide insight into
the interferon response differences between the cytopathic and non-cytopathic biotypes.
However, from these few studies little significant knowledge has been gained as to the
genetics of cattle associated with susceptibility or resistance to PI of BVDV.

RNA-Seq
The transcriptome consists of the complete quantity of transcripts in a cell/tissue
for the specific stage of development and physiological conditions at the time in which
the cell/tissue was sampled. The goals of transcriptomic analyses are to capture all
mRNA, determine the transcriptional structure of genes, splicing variations, and to
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quantify the expression levels under varying conditions (Wang et al., 2009). Sequencing
approaches to RNA, termed RNA-Seq, directly determines the cDNA sequence and has
revolutionized how transcriptomes are analyzed. A population of RNA, total or selected,
is converted to a library of cDNA fragments with adaptors attached to one or both end
depending on single-end or pair-end sequencing methods. Reads can range in size from
30-500bp depending on the high-throughput sequencing technology applied (Emrich et
al., 2007; Holt and Jones, 2008; Marioni et al., 2008). Sequenced reads are then aligned
to a reference genome, a reference transcriptome, or assembled de novo to produce a map
outlining transcript structure and quantity. An advantage is that RNA-Seq is not limited
to detecting transcripts that correspond to existing annotated genomic sequence which
makes RNA-Seq an attractive method for non-model organisms (Vera et al., 2008).
RNA-Seq has the unique ability to identify the precise boundaries of transcription to a
single nucleotide base and how exons are connected. RNA-Seq can also identify
sequence variations like SNPs in the transcribed regions so DNA sequencing may not be
a necessary addition (Cloonan et al., 2008; Morin et al., 2008). RNA-Seq is limited only
by the number of reads collected and can illustrate a large dynamic range of expression.
For example, a greater than 9,000 fold change in expression was estimated in a study that
analyzed 16 million aligned reads and fold change differences spanning five orders of
magnitude were estimated from a study with 40 million reads (Mortazavi et al., 2008;
Nagalakshmi et al., 2008). With this range for detection RNA-Seq out powers
microarrays which lack sensitivity for high and low expressed transcripts. With
quantitative PCR serving as a control, RNA-Seq has demonstrated that it quantifies
transcripts with high accuracy. The results also demonstrate high levels of reproducibility
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for both technical and biological replicates (Cloonan et al., 2008; Nagalakshmi et al.,
2008).
There are several challenges that accompany RNA-Seq that should be addressed.
First, RNA must be fragmented into small pieces to be compatible with the majority of
deep-sequencing technologies. There are two methods, RNA fragmentation and cDNA
fragmentation, which can be utilized to address this requirement but each method comes
with its own resulting bias. RNA fragmentation creates a small bias towards the transcript
bodies and lowers the quantity of transcript ends (Mortazavi et al., 2008). On the other
hand, cDNA fragmentation strongly biases towards the 3’ ends but can provide valuable
information for location (Nagalakshmi et al., 2008). In addition, during amplification
short reads could possibly reflect a true projection of abundance or could be PCR
artifacts. Another consideration is to prepare strand specific libraries which have the
advantage of revealing transcript orientation which is valuable for annotation, and now is
considered to be a standard practice in library preparation (Cloonan et al., 2008; Dutrow
et al., 2008; Lister et al., 2008; Wilhelm et al., 2008). For large and complex
transcriptomes it is difficult to map reads that span splice junctions due to alternative
splicing and trans-splicing, and mapping is complicated further by reads that can match
multiple locations in the genome (Mortazavi et al., 2008; Wilhelm et al., 2008). To detect
rare transcripts and variants considerable coverage and depth are needed which can
increase the sequencing cost. Increased depth is required for adequate coverage of large
and complex transcriptomes, but there is not a common method to calculate the needed
coverage due to the unknown variation of isoforms and quantities of transcripts.
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Despite these challenges, RNA-Seq has provided great insight into
transcriptomics. With its high dynamic range and resolution, RNA-Seq has identified
numerous novel transcription regions, splicing isoforms, and mapped 5’ and 3’
boundaries for multiple genes across multiple species. RNA-Seq will provide a unique
method to study the differences between diseased and healthy animals as well as
differences between physiological states over time.
Bovine viral diarrhea virus is a not an emerging virus, but little is understood of
the interactions between the host’s genetics and the virus. To improve animal production
and welfare, further research is needed to identify relationships for susceptibility and
resistance to persistent infection. Between selection for resistance and improving current
methods of control, the possibilities of potential eradication grow exponentially. To fulfill
the need of genetic knowledge, this research utilized RNA-Seq to identify the variation of
gene expression of persistently infected cattle to discover loci and markers of association
for future selection.
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CHAPTER II: THESIS
Introduction
Persistent Infection (PI) with Bovine Viral Diarrhea Virus (BVDV) is a major
source of economic loss for the livestock industry (Loneragan et al., 2005; Hessman et
al., 2009). Persistent infection occurs when a dam is exposed to the virus during 42 to
125 days of gestation and the virus is passed to the fetus without an adaptive immune
response, in other words the virus is recognized by the calf as “self” (McClurkin et al.,
1984; Brownlie et al., 1989). These PI calves serve as continuous sources of infection to
others. The identification of differences in expression of gene networks and/or genetic
markers associated with infection could assist in the development of novel strategies to
prevent, control, or treat BVDV. The purpose of this study was to utilize RNASequencing (RNA-Seq) to identify gene networks uniquely expressed in BVDV-PI beef
cattle to further the knowledge of how these animals coexist with the virus. This
knowledge will provide the groundwork for developing selective breeding programs to
minimize the effects of the virus. The information gained may also lead to an
improvement of current vaccinations, and may provide insight into alternative treatments.
By improving the understandings of persistent infection in bovine, the translational basics
will help to improve the prevention, diagnosis, and treatment of chronic infections of
familial viruses in humans.
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Methods
Animal Identification and Classification
A Kansas feedlot was identified in which all incoming animals are tested for
BVDV by an antigen capture ELISA and, if positive for the virus, they are penned
separately to limit the spread of infection. The feedlot was visited in April 2014, when
samples were collected from all cattle that tested positive for BVDV upon entry (n=132).
These infected animals were retested three weeks later for PI status by a second antigen
capture ELISA at the UNL Diagnostic Laboratory, utilizing an ear notch for
immunohistochemistry confirmation. 30ml whole blood samples for RNA and DNA
sequencing were also drawn at this time and split into Tempus tubes (Life Technologies)
and EDTA tubes respectively.
Viruses isolated from each individual were classified by strain and subtype using
polymerase chain reaction (PCR) of the 5’ untranslated region (UTR). To confirm the
genotypes of the BVDV-2 strains, whole-genome sequences of the viruses were
generated as a comparison to the 5’ UTR sequence classifications which grouped all nine
viruses under the BVDV-2a subtype (Workman et al., 2016).
After BVDV-PI status was confirmed, the 132 animals were divided into
subgroups by virus strain and subtype. Since breed compositions were unknown,
individuals included in the transcriptome analysis were then selected so there would be
an even distribution of phenotypic characteristics including coat color, presence or
absence of horns, and ear size represented in each group (Appendix A).
In addition to PI cattle, two comparison groups were utilized. One termed “high
exposure” was comprised of individuals collected from the same pen as the PIs. These
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animals initially tested positive for the virus upon feedlot entry, but when retested for
BVDV-PI, were confirmed negative. The second comparison group represents
uninfected, unexposed individuals from a closed herd at the USDA Meat Animal
Research Center (USMARC; Clay Center, NE) that had no previous record of exposure
to the virus (“unexposed”; Appendix A). Overall 45 individuals were included in the
RNA-Seq analyses (10 BVDV-1a, 8 BVDV-1b, 8 BVDV-2, 9 high exposure, and 10
unexposed; Appendix A).

RNA-Seq Analyses
Total RNA was isolated from whole blood collected in Applied Biosystems
Tempus Blood RNA tubes for RNA-Seq using the Applied Biosystems Tempus Spin
RNA Isolation Kit. RNA integrity and concentration was quantified with an Agilent
BioAnalyzer (Agilent Technologies, Santa Clara, CA) using the Agilent RNA 6000 Nano
Kit for total eukaryotic RNA (Appendix A). An Illumina TruSeq Stranded mRNA
Library Prep Kit with was used to construct cDNA libraries; six libraries were created at
one time with each batch containing individuals classified as PI, uninfected, and high
exposure. These libraries were sequenced as 75 base pair (bp), paired-end reads with an
average insert size of 300 bp on an Illumina NextSeq across four lanes at the USMARC.
Read quality was assessed with FASTQC (Andrews, 2010), trimmed with Trim
Galore! (Krueger, 2015), and reassessed for quality improvement with FASTQC
(Appendix B). The sequence reads were then aligned to a ribosomal RNA (rRNA) and
mitochondrial RNA (mRNA) containing GTF file with Tophat 2.1 (Kim et al., 2013);
Appendix B). The remaining reads that failed to align to the rRNA and mRNA file were
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then sorted, split back into fastq pair files, and aligned to the UMD3.1 bovine genome
with the full GTF file for gene annotation (Appendix B). The resulting aligned read files
were then merged into one file per individual and inputted into Salmon (Patro et al.,
2015) for transcript quantification (Appendix B).

Differential Expression Analyses
The number of reads quantified by Salmon were inputted into edgeR, a R package
from Bioconductor, for differential expression (DE) analysis (Robinson et al., 2010;
Appendix B). The transcript counts were filtered by removing those reads that had less
than one count per million in sample size n where n was equal to the smallest number of
individuals in a group. A multidimensional scaling (MDS) plot of the biological
coefficient of variation (BCV) was generated to visualize the heterogeneity of the
expression among and between the groups. In order to examine the differences on a
transcript level, pair wise comparisons were tested using ANOVA in R. The comparisons
were BVDV-1a versus BVDV-1b, BVDV-1 versus BVDV-2, BVDV-PIs versus high
exposure, BVDV-PIs versus unexposed, and high exposure to unexposed. These
comparisons had false discovery rate (FDR) values calculated at the transcript level to
account for multiple testing. Significant differentially expressed transcripts were defined
by having a FDR less than 0.05. A secondary threshold, log fold change (logFC), of
greater than two or less than negative two was also implemented.
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Outlier Detection
Animals acting as outliers within each group were identified by visually
examining the MDS plots based upon BCV. To visualize outliers within each group more
clearly, the BCV plots containing only animals within each group (BVDV-PI, high
exposure, unexposed) were used.
To gain a different perspective on possible outlier detection the variable plotted
was changed from BCV to logFC. Plots were examined when including all individuals,
and after removing the unexposed and high exposure groups.

Differential Expression - Outliers Removed
After removing the outlier libraries, the reduced data was rerun through the edgeR
script for DE analysis. An example of one of the pair-wise comparisons run was with the
transcript counts of the three BVDV-PI groups added together, divided by a factor of
three and then subtracting the value for the high exposure group. As there were 21
BVDV-PIs, a DE analysis was also run comparing the high exposure group (n=9) to nine
BVDV-PIs, three from each virus classification, to address the issue of potential
differences arising from the group size variation. These nine BVDV-PIs were selected
from a close grouping on the logFC plot generated with only the BVDV-PIs and
represented three animals, each, infected with BVDV-1a, BVDV-1b and BVDV-2
strains.
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Manual Transcript Normalization
After the identification of the DE transcripts from the comparison between
BVDV-PIs (n=21) and high exposure groups, the individual transcript counts were
examined for each library in order to detect any individuals that appeared to be driving
the DE. Any individual with a transcript count greater than two standard deviations from
the group mean was deemed a count outlier; the transcript count for these individuals was
replaced with the average of their representative group (excluding the outlier individual).
DE analyses were then conducted on the modified data set.

Ingenuity Pathway Analysis
The comparison transcript data from the BVDV-PI versus the high exposure
group were uploaded into Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City,
www.qiagen.com/ingenuity) with a false discovery rate (FDR) threshold of 0.05, and a
logFC threshold of greater than two or less than negative two.

Results
Animal Identification and Classification
From the suspected BVDV-PI individuals (n=132) at the feedlot, 113 were
confirmed positive, 7 atypical, and 12 negative. The confirmed BVDV-PI individuals
were further classified by strain subtype resulting in identification of BVDV-1b (n=94),
BVDV-1a (n=10), and BVDV-2 (n=9). The BVDV-2 strains were identified as BVDV-2a
(n=4), BVDV-2c (n=2), and some intermediate BVDV-2? (n=3; Workman et al., In
Review). Persistently infected animals within each viral strain, BVDV-1a, BVDV-1b,
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BVDV-2, were selected to form homogeneous groups based off of phenotypic
characteristics and were used for RNA-Seq (n=45; Appendix A).

RNA-Seq Analyses
All extracted RNA for cDNA libraries had a RNA Integrity Number (RIN) > 8.
Next-generation sequencing resulted in 2,615,639,318 total reads with an average of
58,125,318/individual. The number of reads lost due to trimming and quality standards
were 8,137,334 (0.3%). Of the total reads, 3,972,902 reads (0.15%) aligned to the rRNA
and mRNA GTF and were excluded from further analyses. Out of the remaining
2,603,529,082 reads, 86% aligned to the UMD3.1 bovine genome.

Multidimensional Scaling Plots
Plotting all samples together, the BVDV-PIs are admixed with the high exposure
animals, but both groups are separated from the unexposed animals (Figure 1.0).

Figure 1.0 MDS plot of the Biological Coefficient of Variation. Each animal’s location is
represented by an “X” followed by the animals’ library number. The viral classification is
denoted by color.
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Differential Expression Analyses
EdgeR analyses showed no transcripts with significant DE when comparing the
two BVDV-1 strains (Table 1.0). These two groups, BVDV-1a and BVDV-1b, were then
merged for the comparison of BVDV-1 and BVDV-2, which also resulted in no
significantly DE transcripts. Moving forward, all of the BVDV-PIs were grouped
together for all comparisons. There greatest number of DE transcripts was observed
between the high exposure and unexposed groups. The lowest number of DE transcripts
was observed between the BVDV-PIs and the high exposure group.

Table 1.0 Differentially Expressed Transcripts. The differentially expressed transcripts
are those that met the threshold limit for false discovery rate of <= 0.05. There were a
total of 13,587 expressed transcripts considered after normalization. The BVDV-1 group
contains all of the BVDV-1a and BVDV-1b animals. *The BVDV-PI group contains all
of the BVDV-1a, BVDV-1b, and BVDV-2 animals. +The Non-PIs group consists of the
high exposure animals as well as the unexposed animals.
Comparison

Differentially Expressed Transcripts

BVDV-1a vs BVDV-1b
BVDV-1 vs BVDV-2
High Exposure vs Unexposed
BVDV-PIs* vs High Exposure
BVDV-PIs* vs Unexposed
BVDV-PIs* vs Non-PIs+

0
0
4,158
1,032
6,271
3,987
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Outlier Detection
The MDS plot based upon BCV of all samples except the unexposed shows the
high exposure group separating from the BVDV-PIs with no distinct outlier individuals
(Figure 1.1). However when plotting only the BVDV-PIs, 6 individuals fit the BCV
criteria of an outlier: libraries number 15, 23, 26, 42, 49, and 34 (Figure 1.2). When the
variable plotted was changed to logFC, the unexposed group separated from the BVDVPIs and high exposure groups (Figure 1.3). Following the same process as plotting with
BCV, the high exposure group separates from the BVDV-PIs with no clear outlying
individuals (Figure 1.4A). The same individuals appeared to be outliers that were
identified by the BCV plot with the exception of library 34 who shifted closer to the other
BVDV-PIs (Figure 1.4B).

Figure 1.1 MDS plot of the Biological Coefficient of Variation of BVDV-PIs and High
Exposure groups. Each animal’s location is represented by an “X” followed by the
animals’ library number. The viral classification is denoted by color.
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Figure 1.2 MDS plot of the Biological Coefficient of Variation of BVDV-PIs
only. Each animal’s location is represented by an “X” followed by the animals’ library
number. The viral classification is denoted by color. Visual outliers are circled.

Figure 1.3 MDS plot of the Log Fold Change. Each animal’s location is represented by
an “X” followed by the animals’ library number. Viral classification is denoted by color.
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Figure 1.4 MDS plots of the Log Fold Change for A) BVDV-PIs and High Exposures,
and B) BVDV-PIs only. Each animal’s location is represented by an “X”, followed by the
animals’ library number and the viral classification is denoted by color. Outliers,
removed from differential expression analyses, are circled.

Differential Expression - Outliers Removed
With a lower normalization threshold due to the removal of the outliers, there
were a total of 13,476 transcripts analyzed for differential expression with 539 transcripts
passing the FDR threshold of 0.05. From these 539 transcripts, 51 surpassed the logFC
threshold. The nine by nine comparison resulted in 12,805 transcripts for analysis with
354 DE transcripts and 28 transcripts over the logFC threshold.
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Ingenuity Pathway Analysis
The most significant conical pathway across all three comparisons, BVDV-PIs
versus high exposure, with outliers removed, and after manual transcript normalization,
was the interferon signaling pathway (Appendix A). The genes identified in this pathway
included ISG15 and OAS1 which were both upregulated in the BVDV-PIs. Included in
the analysis results were significant networks with known biological associations
(Appendix A). Networks associated with antimicrobial and inflammatory responses were
commonly found across the three BVDV-PIs versus high exposure comparisons.

Manual Transcript Normalization
Manual transcript normalization of the data resulted in seven fewer transcripts
meeting the thresholds set for analysis in edgeR. With 13,469 transcripts available, there
were 527 DE transcripts, slightly fewer than before manual normalization. Of these, 35
transcripts passed the logFC threshold. All 35 of these transcripts previously passed all
thresholds without manual count normalization.

Table 1.1 BVDV-PIs versus High Exposure Differentially Expressed Transcripts.
Differentially expressed transcripts that met the false discovery rate and log fold change
thresholds and were uploaded into IPA. Those with no associated name are identified as
novel transcripts. The asterisk represents the associated gene names of an orthologous
transcript annotated in another species. The plus symbol represents transcripts with
known orthologs identified for pathway analysis.
Ensembl Transcript ID

logFC

FDR

Associated Gene Name

ENSBTAT00000009798+
ENSBTAT00000004093
ENSBTAT00000019477+
ENSBTAT00000011146+
ENSBTAT00000066038
ENSBTAT00000026613+
ENSBTAT00000061135+

2.15
3.97
3.21
2.33
2.74
2.46
2.43

7.05E-06
6.46E-05
6.34E-06
5.40E-05
5.40E-05
5.22E-06
5.22E-06

C2
IFI27*
OAS2
MX2
BST2*
CMPK2
PLEKHA4
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ENSBTAT00000028036+
ENSBTAT00000021373+
ENSBTAT00000022896
ENSBTAT00000001496
ENSBTAT00000044986
ENSBTAT00000043762+
ENSBTAT00000048651+
ENSBTAT00000016856+
ENSBTAT00000018757+
ENSBTAT00000017523+
ENSBTAT00000015014
ENSBTAT00000015085+
ENSBTAT00000061306+
ENSBTAT00000057360
ENSBTAT00000020716+
ENSBTAT00000045436
ENSBTAT00000045468
ENSBTAT00000045694+
ENSBTAT00000004444
ENSBTAT00000010659+
ENSBTAT00000046532
ENSBTAT00000037545
ENSBTAT00000022034
ENSBTAT00000015237+
ENSBTAT00000017547+
ENSBTAT00000002019
ENSBTAT00000019573+
ENSBTAT00000051987

3.42
3.15
2.49
-3.37
2.25
2.79
2.60
3.10
3.40
2.93
2.19
-6.44
-2.71
-4.02
2.45
2.04
2.43
-2.28
2.97
-3.44
-3.03
-2.86
-2.86
2.07
2.83
2.56
2.77
-3.54

3.25E-05
2.76E-05
2.14E-06
2.09E-05
1.96E-06
1.95E-06
1.52E-06
1.52E-06
1.52E-06
1.50E-05
1.02E-05
0.032732
0.027881
0.018796
0.012204
0.011622
0.009831
0.007061
0.003284
0.002557
0.00217
0.001785
0.001785
0.000582
0.00045
0.00024
0.000161
0.000154

ADM
RSAD2
ADAMDEC1
OAS1X
FAM3B
IFI44
OAS1*
CCL8
SIGLEC1
C1R
TMEM259
MYH7
RRAGA*
SLCO2B1
C2
C4A/B*
HBD/B
IFI27*
CRTAC1
HBA1/2*
HBA1/2*
BATF2
TIMD4
OAS1X
ISG15
PNP*

Table 1.2 BVDV-PIs versus Unexposed Differentially Expressed Transcripts.
Differentially expressed transcripts that met the false discovery rate and log fold change
thresholds and were uploaded into IPA. Those with no annotated name in UMD3.1 are
identified as novel transcripts. The asterisk represents associated gene names of an
orthologous transcrpit.
Ensembl Transcript ID
LogFC
FDR
Associated Gene Name
-2.14
1.04E-12
ENSBTAT00000064245
-2.02
2.35E-12
SLC4A11
ENSBTAT00000039338
-2.18
7.06E-12
GPC2
ENSBTAT00000011679
-2.53
9.35E-12
SCUBE3
ENSBTAT00000012158
-2.03
1.28E-11
CCDC168*
ENSBTAT00000023278
-2.76
2.37E-11
SLC16A4
ENSBTAT00000020444
-2.19
3.67E-11
ENSBTAT00000064024
-2.49
8.90E-11
RAPGEF5
ENSBTAT00000033832
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ENSBTAT00000027771
ENSBTAT00000006265
ENSBTAT00000065643
ENSBTAT00000057593
ENSBTAT00000063826
ENSBTAT00000052450
ENSBTAT00000010544
ENSBTAT00000055354
ENSBTAT00000065355
ENSBTAT00000046675
ENSBTAT00000063652
ENSBTAT00000015631
ENSBTAT00000044746
ENSBTAT00000055272
ENSBTAT00000022254
ENSBTAT00000014364
ENSBTAT00000004093
ENSBTAT00000034686
ENSBTAT00000064489
ENSBTAT00000050251
ENSBTAT00000009441
ENSBTAT00000015593
ENSBTAT00000024391
ENSBTAT00000050712
ENSBTAT00000020194
ENSBTAT00000001496
ENSBTAT00000017363
ENSBTAT00000030760
ENSBTAT00000000339
ENSBTAT00000065429
ENSBTAT00000026930
ENSBTAT00000024381
ENSBTAT00000035191
ENSBTAT00000006557
ENSBTAT00000016414
ENSBTAT00000006358
ENSBTAT00000004562
ENSBTAT00000057500
ENSBTAT00000037768
ENSBTAT00000033863
ENSBTAT00000006512
ENSBTAT00000018130
ENSBTAT00000017420

-2.26
-2.27
-2.34
2.24
-3.55
-2.28
2.05
-2.75
-2.75
-2.42
-2.28
-2.01
-2.08
-2.47
-2.00
2.29
3.41
-2.07
-2.18
-2.22
2.94
-2.18
3.73
-2.56
2.29
-2.55
2.26
3.98
2.35
-3.80
-2.01
-4.15
5.79
-2.02
3.71
3.30
4.71
2.57
2.98
4.86
-2.35
2.41
4.81

1.98E-10
6.41E-10
8.76E-10
2.58E-09
4.07E-09
1.09E-08
1.10E-08
1.32E-08
1.94E-08
3.05E-08
5.98E-08
9.09E-08
1.67E-07
1.84E-07
2.38E-07
4.37E-07
1.14E-06
1.38E-06
2.18E-06
2.92E-06
3.30E-06
3.58E-06
5.31E-06
6.81E-06
7.67E-06
1.09E-05
1.11E-05
1.49E-05
1.71E-05
2.91E-05
3.11E-05
3.22E-05
3.53E-05
6.74E-05
8.99E-05
0.000101
0.000115
0.000116
0.000169
0.000179
0.000228
0.000231
0.000248

MEGF6
SCN4A
SYT2
ELN
UTY
ATAD2
BST2*
HTR3E
CDC14A

PPP1R12B
GLTSCR1
ADAM28
RASAL1
GZMH*
IFI27*
KCNJ16
C11ORF95
NINL*
PDGFRA
TLL2
CLEC3B
NINL*
PRSS23
ADAMDEC1
FRMD4B
IL5RA
GTPBP1
WNT5A
PAOX
ABR
GPLD1
C1S
DCN
HSPA6
EIF4G3
COL3A1
FAM84A
KLRG1
COL1A1

44

ENSBTAT00000009467
ENSBTAT00000014055
ENSBTAT00000004627
ENSBTAT00000028617
ENSBTAT00000020716
ENSBTAT00000064073
ENSBTAT00000004444
ENSBTAT00000050266
ENSBTAT00000029208
ENSBTAT00000015085
ENSBTAT00000007924
ENSBTAT00000063354
ENSBTAT00000015668
ENSBTAT00000025663
ENSBTAT00000066019
ENSBTAT00000019758
ENSBTAT00000064533
ENSBTAT00000046279

-2.15
2.46
2.18
4.70
2.43
6.40
2.06
2.05
3.81
-3.88
2.57
-2.58
2.20
2.14
2.39
2.21
2.12
2.02

0.000251
0.0005
0.000536
0.000553
0.000924
0.000954
0.000983
0.003079
0.003514
0.003586
0.005116
0.012218
0.014185
0.015743
0.015787
0.016151
0.019613
0.047571

SIDT2
PRG3*
THADA
COL3A1
SLCO2B1
NCL*
IFI27*
ACTA2
TMEM259
LYZ*
ANO8
COL6A1
CLEC3B
TRAV8*
SPARC
HLA-DQB1/2*

Table 1.3 High Exposure versus Unexposed Differentially Expressed Transcripts.
Differentially expressed transcripts that met the false discovery rate and log fold change
thresholds and were uploaded into IPA. Those with no annotated name are identified as
novel transcripts. The asterisk represents associated gene names of an orthologous
transcript.
Ensembl Transcript ID

LogFC

FDR

Associated Gene Name

ENSBTAT00000023278
ENSBTAT00000020444
ENSBTAT00000064245
ENSBTAT00000063652
ENSBTAT00000022896
ENSBTAT00000018496
ENSBTAT00000024084
ENSBTAT00000065429
ENSBTAT00000017847
ENSBTAT00000020277
ENSBTAT00000018746
ENSBTAT00000011679
ENSBTAT00000052450
ENSBTAT00000035354
ENSBTAT00000005261
ENSBTAT00000038286
ENSBTAT00000035191
ENSBTAT00000033863

-2.04
-2.81
-2.45
-3.33
-3.75
-2.76
-2.11
-10.09
-2.51
-2.49
-2.01
-2.12
-3.06
-2.34
-2.30
-2.22
6.88
3.79

3.55E-09
6.26E-08
6.39E-08
7.49E-08
8.78E-08
1.66E-07
1.69E-07
1.79E-07
2.16E-07
2.62E-07
2.74E-07
3.34E-07
7.53E-07
1.09E-06
1.40E-06
1.72E-06
2.12E-06
2.29E-06

CCDC168*
SLC16A4

HERC2
KMT2A
GTPBP1
NFAT5
UBR4
MBNL3
GPC2
ATAD2
SLFN12*
LCOR*
INO80D
ABR
COL1A2
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ENSBTAT00000017420
ENSBTAT00000065285
ENSBTAT00000014551
ENSBTAT00000010591
ENSBTAT00000006265
ENSBTAT00000019193
ENSBTAT00000055354
ENSBTAT00000030444
ENSBTAT00000057049
ENSBTAT00000064969
ENSBTAT00000064608
ENSBTAT00000065887
ENSBTAT00000044746
ENSBTAT00000035892
ENSBTAT00000000339
ENSBTAT00000038788
ENSBTAT00000014364
ENSBTAT00000019477
ENSBTAT00000065355
ENSBTAT00000007811
ENSBTAT00000027080
ENSBTAT00000014055
ENSBTAT00000027024
ENSBTAT00000014612
ENSBTAT00000065082
ENSBTAT00000001810
ENSBTAT00000065956
ENSBTAT00000042717
ENSBTAT00000017363
ENSBTAT00000050251
ENSBTAT00000031648
ENSBTAT00000015631
ENSBTAT00000063826
ENSBTAT00000015911
ENSBTAT00000016989
ENSBTAT00000050712
ENSBTAT00000012835
ENSBTAT00000064234
ENSBTAT00000030760
ENSBTAT00000066254
ENSBTAT00000054450
ENSBTAT00000038558
ENSBTAT00000009467

3.75
-2.17
-2.12
-2.04
-2.23
-2.66
-3.35
-2.08
-2.07
-2.30
-2.64
-2.03
-2.49
-2.21
3.35
2.35
2.31
-2.86
-2.71
2.44
3.15
2.58
2.05
-2.31
-2.16
2.24
-2.01
2.28
2.27
-3.17
2.34
-2.04
-3.55
2.13
2.34
-2.28
2.07
3.58
3.53
2.44
2.95
2.41
-3.21

2.35E-06
2.83E-06
3.01E-06
3.15E-06
4.06E-06
4.08E-06
4.60E-06
5.92E-06
5.92E-06
7.17E-06
8.38E-06
8.81E-06
9.83E-06
1.12E-05
1.84E-05
2.33E-05
2.39E-05
3.25E-05
3.56E-05
3.67E-05
4.32E-05
5.54E-05
6.53E-05
7.75E-05
7.76E-05
9.59E-05
0.000114
0.000121
0.000126
0.000129
0.000155
0.000164
0.000177
0.000233
0.000382
0.000383
0.000441
0.000469
0.000487
0.000602
0.000768
0.000808
0.000879

COL1A1
NBEAL1
HECTD4*
GCFC2
SCN4A
KMT2D
HTR3E
RNF213
OTUD3
GOLGB1
ZNF24
GLTSCR1
DMXL2
IL5RA
SV2B
GZMH*
OAS2
CDC14A
CEBPE
ALOX5
PRG3*
HPGD
CCDC136
OTUD3
CLDN3
PIK3R5
VCAN
NINL*
PPP1R12B
UTY
ALOX15
MPO
NINL*
FBP1
PIK3CB
FRMD4B
HBM
ASB2
SIDT2
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ENSBTAT00000037768
ENSBTAT00000011308
ENSBTAT00000006337
ENSBTAT00000024381
ENSBTAT00000045694
ENSBTAT00000006557
ENSBTAT00000017538
ENSBTAT00000066115
ENSBTAT00000065187
ENSBTAT00000048965
ENSBTAT00000064533
ENSBTAT00000022034
ENSBTAT00000037545

2.98
-2.54
2.41
-3.64
2.94
-2.34
2.27
2.37
-2.59
2.14
2.60
2.60
2.60

0.001567
0.003188
0.003217
0.003461
0.00358
0.003901
0.004256
0.004586
0.007424
0.012314
0.016715
0.019347
0.019347

EIF4G3
ZFP36
REEP1
PAOX
HBB
GPLD1
ALAS2
SRBD1
CREBRF
MLH1
HBA1/2*
HBA1/2*

Discussion
Identification of Samples
The retesting of putative BVDV-PI cattle three weeks after their arrival at the
feedlot proved to be a valuable exercise in the conformation of PI status as not all animals
were conclusively PI. These results provided the unique opportunity for the inclusion of
the high exposure group of animals for comparison to the BVDV-PIs. The high exposure
animals were penned with the BVDV-PI individuals due to their initial positive test for
the presence of the virus, and were most likely experiencing an acute infection at time of
arrival. Due to the three week difference in retesting the high exposure animals most
likely had residual expression from an acute infection. The atypical status from PI
confirmation testing was derived from the immunohistochemistry results not clearly
being confirmed or denied. All individuals included were selected based on phenotypic
characteristics to balance and neutralize the possible effects of identification of
phenotypic specific expressional differences.
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Viral Classification
While 5’ UTR amplification has been the standard method for BVDV strain and
subtype classification, there is 70% sequence similarity in this region between BVDV-1
and BVDV-2. In order to confidently classify the viral strains, whole genome sequence
data of the BVDV-2 strains were produced for comparison resulting in subdivisions. The
conventional 5’UTR method classified all nine BVDV-2 viruses as BVDV-2a while the
whole genome sequence data confirmed the presence of BVDV-2c and BVDV-2 of
unidentified strains (Workman et al., 2016). This information is valuable since BVDV-2a
is considered to be the predominate strain of BVDV-2 in the United States (Fulton et al.,
2005). These data suggest that the commonly used method of classification (5’ UTR)
may not be accurately capturing the diversity of the pathogen in the US. These also allow
for better monitoring of shifting viral demographics, which is important to consider when
implementing control strategies. Despite the newly discovered variety among BVDV-2
strains, due to the limited numbers of the subtypes, all nine BVDV-2 individuals were
grouped together for the analyses.

Differential Expression Analyses
Salmon was selected for transcript quantification due to the robustness of the
quasi-mapping method it utilizes. Instead of base to base alignment, quasi-mapping uses
a k-mer length that acts as a minimum acceptable length of sequence for a valid match to
a known transcript. This alignment method allows for sequence variation as well as
differential splicing to be have a greater chance of being properly assigned and
quantified.
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The arrangement of the animals in the inclusive BCV MDS plot suggests that the
animals are not separating by phenotypic characteristics or breed specific genetics and
supports the selection effort to neutralize these differences between groups (Figure 1.0).
Instead, the expression patterns of the BVDV-PIs are more similar to the high exposure
animals while greatly differing from the unexposed animals. With the least amount of DE
transcripts between the high exposure group and the BVDV-PIs and the most difference
between the BVDV-PIs and the unexposed, uninfected group, the ANOVA comparisons
support the BCV plot (Table 1.0). The large difference between the BVDV-PIs and the
unexposed group could be due to the difference in timing and geographic location of
when the RNA sampling occurred; samples were drawn April, 2014, for the BVDV-PIs
and May, 2015, for the unexposed animals. Due to the concern that the DE between the
unexposed group and others may be driven by factors other than infection status, the
unexposed group was removed from the main analyses. At the same time, the limited
difference between the BVDV-PIs and the high exposure group could imply a common
innate immune response to BVDV.
There were no transcripts that were significantly DE between the BVDV-1a and
the BVDV-1b subtypes, as well as between the BVDV-1 and BVDV-2 strains. This result
was unexpected due to previous research which has demonstrated expression differences
in response to different strains, different subtypes, and even viruses of the same strain and
subtype (Gibson et al., 2011; Rajput et al., 2014). On the other hand, these experiments
are conducted in vitro with single bovine cell lines and types while our data resulted from
whole blood drawn from naturally infected PI cattle. The differences among the studies
may also be due to acute nature of the in vitro studied infection versus our study of
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persistent infection which results in observable physiological response differences. The
response difference to the strains and subtypes may be different when there is a persistent
infection that is established at an early time in the development of the immune system;
transient infections occur after the immune system is fully developed and have the
potential to be exposed to plural pathogens.

Outlier Removal
When identifying probable outliers, six samples clearly clustered apart from the
others when plotting both the BCV and logFC variables. Library number 34 was
positioned between the outliers and the rest of the PIs (Figure 1.2). In the logFC plots
Library 34’s location shifted closer to the PIs and further away from the other 5
individuals and thus was ultimately not included as an outlier (Figure 1.5). Removal of
these outliers was performed in order to make sure the groups were homogeneous
representatives of their physiological states. If one individual is drastically different in
expression patterns from the rest of the group then when the group as a whole is
considered it is not a true representation of the current physiological state.

Manual Transcript Normalization
Differential gene expression can be swayed by wide variation within each
group resulting in false positives or negatives. In order to identify any possible outlier
transcript counts, which may be due to PCR bias, any count outside of two standard
deviations from the mean of the was replaced with the group mean excluding the outlier.
Several DE transcripts were affected by this process. Of the 51 transcripts that were DE
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and passed the logFC threshold after removal of the outlier individuals, 35 of these
transcripts remained meeting the criteria for significant DE after manual normalization.
From the 16 transcripts that did not remain significant, 4 were DE (FDR < 0.05) but did
not meet the logFC threshold; the other 12 were no longer significantly DE as defined by
FDR. Due to these results we believe that we were able to reduce our within group
variation while retaining the integrity of our data. An example of one transcript that was
influenced by a single extreme count was ENSBTAT00000010295 (Appendix A). This
transcript, belonging to the gene TG (thyroglobulin), was the top DE transcript with a
logFC of -8.145. Upon inspection of the raw counts, it was observed that 214,064 reads
of this transcript were observed in one individual (library 40), while the mean of the
others in the group was 142.5 (range 58 to 262). After normalization of only that
individual, the transcript is no longer DE. In these instances, the individuals themselves
were not outliers, but the single transcript count was suspect.

Ingenuity Pathway Analysis
When the data from the ANOVA comparison between all BVDV-PIs versus the
high exposure group was uploaded into IPA, the top canonical pathways represented
included interferon signaling, role of pattern recognition receptors in recognition of
bacteria and viruses, and cardiomyocyte differentiation via bone morphogenetic protein
receptors (Appendix A). These three canonical pathways remained present through the
analyses even with the removal of the outliers and the manual transcript count
normalization which suggests the results are indicating processes unique to BVDV-PIs
and were not driven by the presence of these outliers. While the gene expression of the
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BVDV-PIs suggests there is an up-regulation of the interferon signaling pathway, there
are genes present in our data set that have known interactions with the virus. MX2 has
been found to be regulated by BVDV due to the RNASE activity of the BVDV Erns
protein which attempts to degrade PAMPs (Peterhans and Schweizer, 2013); however,
this gene’s increased expression in the BVDV-PIs as compared to the high exposure
animals causes IPA to predict an increase in the interferon signaling pathway.

Figure 1.5 Interferon Signaling Pathway of BVDV-PIs verse High Exposure. Genes
highlighted in color are represented in our data set. Red shading indicates upregulation in
the BVDV-PIs

An upstream regulator of MX2 in the interferon pathway is IRF3 which is also
known to be regulated by the virus at a protein level (Chen et al., 2007). Due to the
increase of gene expression in the interferon pathway, it would be logical to conclude that
the BVDV-PIs are mounting an interferon response. On the other hand, the BVDV-PIs do
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not have a detectable interferon response due to the efforts of the virus. The observed
gene expression data is possibly driven by an innate immune response to the virus which
is halted at the protein level before it can progress any further.
Networks related to the inflammatory response, antimicrobial response, and cell
signaling are identified among all three BVDV-PI versus High Exposure comparisons.
All three of these networks have roots with the innate immune response which can also
have effects that tie into the identified network association of carbohydrate metabolism.
The continuous innate response since the birth of the animal could possibly explain why
there are many networks being identified with associations to development.
Based upon prior data, BVDV-PIs should not be having an innate immune
response since the virus is introduced during the development of the immune system. Due
to this early timeframe, BVDV-PIs are not able to produce antibodies against the virus
and are considered to be immunotolerant. Tolerance is classified into central tolerance or
peripheral tolerance and both relate to antibodies. Central tolerance refers to the deletion
of autoreactive lymphocytes before they fully develop. This process is done in order to
preserve the response to antigens while protecting the host’s tissues. Peripheral tolerance
occurs after T and B cells mature to prevent lymphocytes from initiating a too strong of a
response which could potentially be dangerous. From the breaking down of the
definitions of the components of immunotolerance, they suggest that this tolerance takes
place specifically at the acute phase response of the immune system while leaving the
innate response fully intact. Our data support this possible conclusion in that BVDV-PIs
do not produce antibodies against the virus but their gene expression patterns suggest
there might be an active innate response.
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Over all, the continuous stress the virus places on the animals’ system as it
develops could be the driving force behind the phenotype of the BVDV-PIs. With a
constant active innate immune response, the animal is forced to alter their normal gene
expression in order to adapt to survive. By studying BVDV-PI gene expression patterns it
is clear that these animals welfare is compromised at a molecular level. Though our
BVDV-PIs were not tested for secondary infection, it could be possible that the
expression patterns observed were from a different pathogen or the combination thereof.

Associated Loci
Prior studies with BVDV have attempted to identify loci associated with PI and
acute infection in calves and their dams. In the studies conducted by Neibergs et al.
(2011) and Zanella et al. (2011), there was identification of loci associated with BVDVPI on BTA2 and BTA26. In contrast, there were no transcripts identified in our data that
were derived from BTA2 and there was only one transcript, ENSBTAT00000010659,
from BTA26. This transcripts associated gene is CRTAC1, but its location is 14Mb away
from the nearest marker used in both prior studies and unlikely driving the signal
observed by Neibergs et al. (2011). In the study conducted by Casas et al. (2015), there
was a genome wide association study conducted which identified several single
nucleotide polymorphisms (SNP) across the genome which may be associated with the
incidence of BVDV-PI. Casas et al. (2015) identified associated SNPs on 1, 6, 8, 10, 15,
and 18, however, all SNPs were minimally 7Mb away from any of our DE transcripts. At
these distances it is unlikely that these results are correlated. While these distances do not
suggest support for their findings, there may be interactions at a protein level or common
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regulatory factors that possibly explain the differences in location while providing
possible support for associated loci.

Expression Studies
Previous studies examining cattle’s gene expression response to BVDV have
identified patterns of interest. In a study conducted by Müller-Doblies et al. (2002), the
authors examined the in vitro response of the MX1 gene to various viruses including
BVDV. The MX1 gene has known antiviral response activities to many viruses that are
induced by type I and II interferons. MX1 was upregulated in response to BVDV, but in
our data MX1 was not significantly DE while MX2 was upregulated. Though, when our
transcript data were uploaded into IPA the bovine MX2 transcript was identified as the
human ortholog MX1 (Figure 1.5). If the bovine MX2 gene has the same antiviral activity
as the human MX1 gene, then the upregulation of MX2 in BVDV-PIs would follow our
hypothesis that they are mounting an innate response.
An in vivo study conducted by Palomares et al. (2013) identified several
interferon related genes that were upregulated in acutely infected cattle. IFN-α and IFN-β
were upregulated in cattle which were infected with a high virulence BVDV-2 strain but
not in cattle infected with a low virulence BVDV-1a strain when compared to a group of
uninfected cattle. MX1, PKR, OAS-1, and ISG15 were all upregulated in both the BVDV2 and BVDV-1a infected cattle, but OAS-1 and ISG15 had significantly greater
expression in the BVDV-1a cattle than the BVDV-2 cattle. IFN-α and IFN-β were not
significantly DE in our data, and this may be due to the persistent infection status in
which the virus continuously tries to block the interferon response. MX1 and PKR were
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not significantly DE in our data either, but this may be due to the RNase activity of the
viral protein Erns which degrades any dsRNA that can activate these two genes. OAS-1
and ISG15were significantly DE with a logFC greater than two in our data which
correlates with the increased expression they detected. While we did not see a significant
difference in expression between the strains in our analyses, this may be due to the
different type of infection, acute versus persistent.
Shoemaker et al. (2009) detected increased expression of interferon related genes
in an in vivo and natural persistent infection study. In their study, MX2, PKR, OAS-1,
ISG15, RIG-I, MDA5, LGP2 and IFI44 had increased expression with a fold change
greater than 1.5 in the PI cattle when compared to the uninfected cattle. MX2, OAS-1,
ISG15, and IFI44 were all significantly DE with the same logFC directionality in our data
which correlates with their results. Meanwhile RIG-I, MDA5, LGP2, and PKR were not
significantly DE in our data. RIG-I and MDA5are both innate immune receptors that
recognize dsRNA and viral nucleic acids respectively, but these were not significantly
DE in our data. LGP2 is a regulator of both RIG-I and MDA5, and is known to have
positive and negative effects on the interferon response. The reason why we might not
have seen these genes DE could be due to the effects of the Erns protein.
With previous studies that have identified the same genes with the same
directionality of DE, these correlating results serve to increase the confidence in our own
results. From the genes mentioned above it appears that the interferon pathway plays a
crucial role in persistent infection and future studies will be needed to identify the
components which allow for increased susceptibility or resistance to BVDV.
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Translational Expression
Bovine viral diarrhea virus persistent infection may be comparable to how chronic
hepatitis c infections (HCV) are able to be established. Due to the familial classification
of these two viruses and that they are both able to survive in their host’s systems for
extended periods of time, some of the knowledge gained from studying one might be
applicable to the other. The top two canonical pathways, interferon signaling and role of
pattern recognition receptors in recognition of bacteria and viruses, are influenced by the
expression of ISG15, OAS1, and OAS2. ISG15 had an expression logFC increase of 2.77
in the BVDV-PIs as compared to the high exposure animals while OAS2 had an increase
of 3.2 and OAS1 was increased by 3.1. In a study conducted by (Chen et al., 2010) there
were data suggesting that HCV exploits ISG15 to increase HCV replication. They found
over expression of ISG15 to increase HCV RNA three fold, and blocking production of
ISG15 largely decreased the replication of the virus. Due to the increased expression of
ISG15 in the BVDV-PIs, these results may be correlated in that a similar chronic
infection of a familial virus may have the same effect. In studies conducted by (Zhao et
al., 2013; Barkhash et al., 2014), polymorphisms in genes OAS1 and OAS2 were
associated with susceptibility and predisposition to chronic hepatitis c infections. While
our expression data does not extend to polymorphism identification, there is greater
expression of these two genes in BVDV-PIs; additional assays would be required to
identify the effect of a polymorphism if one were present. Chronic hepatitis c has been a
more widely studied virus when examining the host’s gene expression response and with
the correlations that can be drawn from similar expression patterns in BVDV-PIs; the
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vast knowledge in human research may assist in furthering our understanding of
persistent infection.

Conclusions and Future Directions
From this experiment, the expression pattern of BVDV-PIs more closely mirrors
that of the high exposure animals as compared to the unexposed animals. While
surprising due to the immunotolerant status of PIs, this knowledge has shed light on
novel interactions between the host and the virus. Not being able to produce antibodies
against the source of PI, BVDV-PI animal’s gene expressions suggest they are attempting
to mount an innate immune response to the virus. Moving forward more research will
need to be done to examine regulatory factors that may have a widespread influence over
multiple genes, and identification of protein interactions with the virus will help explain
the differences observed between expression and actualization of the immune system.
While there was identification of gene networks possibly unique to BVDV-PIs, which
may influence susceptibility, there will need to be further studies conducted to narrow the
scope before this information can be utilized in a selective breeding program.
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APPENDIX A
1.0 Table of cDNA Libraries
Animal ID
11
27
29
51
57
77
88
91
96
127
6
12
39
40
46
70
72
107
15
37
61
65
76
83
92
106
20143009
20143102
20143112
20143140
20143164
20143234
20143410
20143442
20143510
20143742
3
14
24
26
50
53

Library ID
28
26
41
17
44
38
22
34
11
50
24
29
43
15
9
49
4
42
31
14
48
10
37
27
6
23
8
20
35
7
39
25
32
16
46
12
30
40
13
47
33
36

Classification
1a
1a
1a
1a
1a
1a
1a
1a
1a
1a
1b
1b
1b
1b
1b
1b
1b
1b
2
2
2
2
2
2
2
2
Unexposed
Unexposed
Unexposed
Unexposed
Unexposed
Unexposed
Unexposed
Unexposed
Unexposed
Unexposed
High Exposure
High Exposure
High Exposure
High Exposure
High Exposure
High Exposure

RIN
10
9.2
9.3
8.9
9.2
8.8
8.7
9.2
9.3
9.4
10
10
8.7
8.5
8.1
9.1
8.9
9.3
9.8
9.3
9.1
9.4
9.2
9.0
8.2
8.3
9.5
9.9
10
10
9.4
9.6
10
10
10
9.6
9.2
9.0
8.9
8.4
8.9
8.9

RNA Concentrations (ng/uL)
112
212
102
193
122
512
192
275
186
231
149
337
122
182
74
42
200
169
135
110
135
89
160
230
131
384
245
476
336
488
239
392
378
579
402
371
129
113
118
83
122
121

59
60
82
124

21
5
45

High Exposure
High Exposure
High Exposure

9.1
8.7
9.4

118
150
235

1.1 Table of Phenotypic Data of Persistently Infected and High Exposure Animals
Animal ID

Viral
Classification

Large
Ears

Horn
Status

Body Color

Head Color

11
27
29
51
57
77
88
91
96
127
6
12
39
40
46
70
72
107
15
37
61
65
76
83
92
106
3
14
24
26
50
53
60

1a
1a
1a
1a
1a
1a
1a
1a
1a
1a
1b
1b
1b
1b
1b
1b
1b
1b
2
2
2
2
2
2
2
2
High Exposure
High Exposure
High Exposure
High Exposure
High Exposure
High Exposure
High Exposure

No
No
No
Yes
Yes
No
No
Yes
No
No
No
No
Yes
No
Yes
Yes
No
No
No
Yes
Yes
No
No
Yes
No
Yes
Yes
No
No
Yes
No
No
No

Horned
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Polled
Horned
Polled
Polled
Polled
Horned
Polled
Horned
Polled
Polled
Polled
Polled
Polled
Polled
Horned

Red and White
Black
Black
Black
Black
Cream
Black
Red
White and Grey
Black and White
Black
Grey and White
Black and White
Black
Black
Red
Black
Red
Brown and White
Black and White
Black
Red and White
Black
Red and White
Black
Tan
Red and Brown
White
Black
Brown and Grey
Red
Black
Grey Brown

White
Black
Black
Black
Black
Cream
Black
Red
White and Grey
Black
Black and White
Grey and White
Black
Black
Black
Red
Black
White
Brown and White
Black
Black
Red
Black and Red
Red and White
Black
Tan
Red and Brown
White
Black
Brown and Grey
Red and White
Black
White

60

82
124

High Exposure
High Exposure

Yes
No

Polled
Polled

Red
Red and White

Red
Red and White

1.2 Table of Phenotypic Data of Unexposed, Uninfected USMARC Animals
Animal ID

Sire Line

Maternal Grand
Sire Line

Color

Sex

20143112
20143140
20143234
20143510
20143442
20143410
20143102
20143164
20143009
20143742

Charolais
Santa Gertrudis
Brangus
Simmental
Hereford
Angus
Simmental
Hereford
Angus
Charolais

Charolais
Santa Gertrudis
Brangus
Simmental
Hereford
Angus
Simmental
Hereford
Angus
Charolais

White
Red
Black
Red
Red and White
Black
Black and White
Red and White
Black
White

M
M
M
M
M
M
F
F
F
F
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1.3 Table of Ingenuity Pathway Analysis Canonical Pathways
IPA Comparison

BVDV-PI vs High
Exposures - All

BVDV-PIs vs High
Exposures - Outliers
Replaced

BVDV-PIs vs High
Exposures - Outliers
Replaced and
Transcripts
Manually
Normalized

Canonical
Pathway

Genes
Represented

Pathway
P-value

Interferon
Signaling
Activation of IRF by
Cytosolic PRR
Role of PRR in Recognition
of Bacteria and Viruses
Hepatic Fibrosis/ Hepatic
Stellate Cell Activation
Cardiomyocyte
Differentiation via BMP
Receptors

ISG15
OAS1
ISG15
ZBP1
OAS1
OAS2
COL8A1
MYH7

1.12 x 10-3

MYH7

2.7210-2

Interferon
Signaling

ISG15
OAS1

9.03 x 10-4

Role of PRR in Recognition
of Bacteria and Viruses
Hepatic Fibrosis/ Hepatic
Stellate Cell Activation
Agranulocyte Adhesion and
Diapedesis
Cardiomyocyte
Differentiation via BMP
Receptors

OAS1
OAS2
COL8A1
MYH7
CCL8
MYH7

1.24 x 10-2

MYH7

2.45 x 10-2

Interferon
Signaling

ISG15
OAS1

5.31 x 10-4

Role of PRR in Recognition
of Bacteria and Viruses
Agranulocyte Adhesion and
Diapedesis
Cardiomyocyte
Differentiation via BMP
Receptors
Role of Lipids / Lipid Rafts
in the Pathogenesis of
Influenza

OAS1
OAS2
CCL8
MYH7

7.42 x 10-3

MYH7

1.89 x 10-2

RSAD2

2.02 x 10-2

3.30 x 10-3
1.53 x 10-2
2.62 x 10-2

2.14 x 10-2
2.27 x 10-2

1.37 x 10-2

62

1.4 Table of Ingenuity Pathway Analysis Networks
IPA Comparison

BVDV-PIs vs
High Exposures
- All

Network Associations

Antimicrobial Response,
Inflammatory Response,
Dermatological Diseases and
Conditions

Carbohydrate Metabolism,
Molecular Transport,
Small Molecule
Biochemistry
Cell Morphology,
Reproductive System
Development and Function,
Drug Metabolism
BVDV-PIs vs
High Exposures
- Outliers
Removed

Antimicrobial Response,
Inflammatory Response,
Cell Signaling

Cardiac Hypertrophy,
Cardiovascular Disease,
Developmental Disorder
BVDV-PIs vs
High Exposures
- Outliers
Removed and
Transcripts
Manually
Normalized

Genes Represented

ADM, BATF2, C2, CCL8,
COL8A1, EPCAM, GBP2, ID1,
IFI44, ISG15, LAMB1,
LAMC2, MX2, OAS1, OAS2,
RSAD2, SIGLEC1, ZBP1, TG,
TIMD4
ADRB3, APP, CMPK2, EEF2K,
ESR1, FAM3B, GAS2, HSPA6,
MYH7, NDRG2, NTHL1,
PDK4, PLEKHA4, PRKAA1,
RAMP3, RGS19, RTP4,
SLCO2B1, TP53
ATP8B4, TMEM30A
ADM, BATF2, C2, CCL8,
CTRAC1, DES, EPCAM,
FAM3B, HSPA6, IFI44, ISG15,
LAMB1, MX2, OAS1, OAS2,
RSAD2, SIGLEC1, SLCO2B1,
TG, TIMD4
B3GALT2, CMPK2, COL8A1,
CPT1A, HBD, IL1B, IL1R2,
LITAF, MARCKSL1, MYH7,
PLEKHA4, SIGLEC1,
SLCO2B1, ST3GLA5, TG,
TGFB1, TMEM259, TNF

Antimicrobial Response,
Inflammatory Response,
Dermatological Diseases and
Conditions

ADM, BATF2, CALCRL,
CCL8, CTRAC1, FAM3B,
IFI44, ISG15, MX2, OAS1,
OAS2, RSAD2, SIGLEC1,
SLCO2B1, TIMD4

Cell Morphology,
Hematological System
Development and Function,
Cell to Cell Signaling and
Interaction

ARID5B, B3GALT2, C2,
CCR3, CMPK2, GBP1, HBD,
IL1B, LGMN, LITAF, MYH7,
NLRX1, OAS2, PLEKHA4,
RNASE1, RNASEL, SIGLEC1,
SLCO2B1, SORD, ST3GLA5,
TGFB1, TMEM173,
TMEM259, TNF
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1.5 Table of Transcript Counts Manually Normalized
Ensembl Transcript ID

Library ID

Original Count

Normalized Count

ENSBTAT00000018757
ENSBTAT00000032398

9
33
40
10
40
48
40
22
9
47
48
43
9
48
43
9
17
38
40
27
27
31
13
10
9
13
9
47
9
47
48
48
43
48
45
44
17
47
38
43

400.35
160.88
224.23
73.88
688.98
87
600.49
429.73
222.26
12.63
94439.2
89094.2
82497.6
94438.4
89094.8
82492.9
145.02
157.04
708.71
342.00
8792.16
8178.94
3355.23
5338.54
5710.67
1127.47
29605.6
6833.86
81221.1
20340.3
36453.4
38729.2
374753
121.3
642.44
167.82
186.88
540.00
1514.9
70485.1

56.37
0.53
0.53
24.25
25.35
28.50
27.63
54.27
48.56
4.37
10651.67
10651.67
10651.67
10651.76
10651.76
10651.76
45.64
45.64
99.13
130.46
2923.69
2923.69
441.16
1314.94
1314.94
163.72
8215.99
790.89
30816.04
3433.09
9187.12
13653.55
60559.29
7.50
44.23
9.30
9.30
78.79
119.71
23321

ENSBTAT00000018159
ENSBTAT00000015166
ENSBTAT00000045468
ENSBTAT00000028036
ENSBTAT00000037545

ENSBTAT00000022034

ENSBTAT00000008487

ENSBTAT00000045436
ENSBTAT00000009798
ENSBTAT00000004093
ENSBTAT00000004444

ENSBTAT00000019477
ENSBTAT00000016856
ENSBTAT00000002019
ENSBTAT00000044986
ENSBTAT00000045694
ENSBTAT00000063938
ENSBTAT00000057360

ENSBTAT00000001496
ENSBTAT00000019573
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ENSBTAT00000020716
ENSBTAT00000048651
ENSBTAT00000010659
ENSBTAT00000021373
ENSBTAT00000026613
ENSBTAT00000043762
ENSBTAT00000011146

ENSBTAT00000022376
ENSBTAT00000017523
ENSBTAT00000015014
ENSBTAT00000061135
ENSBTAT00000012124
ENSBTAT00000066038

ENSBTAT00000030444
ENSBTAT00000022896
ENSBTAT00000007041
ENSBTAT00000010295
ENSBTAT00000015237
ENSBTAT00000015085
ENSBTAT00000061306
ENSBTAT00000051987
ENSBTAT00000042779
ENSBTAT00000017547
ENSBTAT00000048087
ENSBTAT00000057306

47
9
47
48
48
47
48
47
9
47
48
9
47
10
33
9
47
27
10
13
9
43
9
47
9
9
22
40
38
40
27
13
50
47
22
40
41
9
47
43
34
47
17

27914.3
828.09
7408.54
268
53437.9
18359.4
14580.7
3962.15
1885.11
922.29
82874.5
79519.8
20272.9
215.57
944.84
4756.06
1092
1560.59
146
24
2617.21
15049.1
15160.5
6467.63
89170.4
7598.2
134.01
342.01
747.07
214064
1103.18
311.01
1314.58
655.73
210.74
1849.96
175.80
160
38
109.04
109.55
276.96
144.69

2968.25
126.97
1109.53
19.80
16929.09
1709.98
4491.77
803.17
760.06
111.43
24677.51
24677.51
4457.32
8.28
37.00
1203.87
162.13
663.75
39.05
6.75
786.37
5356.84
5356.84
828.23
25870.27
1553.30
12.58
22.63
124.35
142.50
389.91
95.77
49.75
46.92
9.79
44.46
4.80
34.90
4.75
33.3
4.65
53.60
6.59
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ENSBTAT00000057500
ENSBTAT00000030625

ENSBTAT00000046532
ENSBTAT00000065672

44
47
37
47
48
17
13
48
30
38
47

120.21
376.43
551.96
11142.9
153.15
101.98
2044.27
137.27
4342.71
103.05
5268.05

6.59
61.17
171.27
208.45
25.40
25.40
73.13
39.46
159.55
46.56
62.83
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APPENDIX B
1.0 Script for Trimming and Quality Assessment

This script runs Trim Galore! and trims the fastq pair files for each library. The
TrimGalorePrime.txt file contains a list of the pair files with the first half of the pair in a
single column and the complementary half in a second column of the same row with a
single space separating the two columns.

1.1 Script for Tophat Filtering Alignment

This script utilizes Tophat 2.1 to align the reads to the
Bos_taurus.UMD3.1.82_MT_RRNA.gtf file in order to filter out any rRNA and mtRNA
reads. The Read_Files.txt contains a list of the pair files with the first half of the pair in a
single column and the complementary half in a second column of the same row with a
single space separating the two columns.
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1.2 Script for Sorting and Splitting

This script was utilized to sort the Tophat 2.1 unmapped.bam files and then to split them
back into pair fastq files for each library and lane. The list.txt file contains a single
column of the library and lane name ex LIB14004_L001.

1.3 Script for Tophat Alignment

This script used Tophat 2.1 to align the paired fastq files for each library to the UMD3.1
bovine genome with the complete GTF file for annotation. The read_files.txt file
consisted of a list of the file names with the first half of the pair in the first column and
the second half in a second column on the same row. This script was run in parallel with
multiple ranges for the array input in order to decrease run time.
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1.4 Script for Salmon Transcript Quantification

This script utilized Salmon to quantify transcripts from the Tophat 2.1 aligned fastq
reads. The Salmonfiles.txt file lists all four pair files in order by lane for each library ex.
LIB14050_L001_end1.fq LIB14050_L002_end1.fq LIB14050_L003_end1.fq
LIB14050_L004_end1.fq LIB14050_L001_end2.fq LIB14050_L002_end2.fq
LIB14050_L003_end2.fq LIB14050_L004_end2.fq.

1.5 Script for edgeR Biological Coefficient of Variation Plot

The input file for this script was called Salmon.csv which contains all of the transcript
counts from each animal in a column/animal.
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1.6 Script for edgeR ANOVA

This script is run after running the previous edgeR script (1.5) and produces a csv file
with the comparison results. It is suggest to run one comparison at a time for ease of
reading the results.

